KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Basic): 2009-2025

Historic EPS (Basic) for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $3.43.

  • Idexx Laboratories' EPS (Basic) rose 21.20% to $3.43 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.72, marking a year-over-year increase of 21.49%. This contributed to the annual value of $10.77 for FY2024, which is 5.90% up from last year.
  • According to the latest figures from Q3 2025, Idexx Laboratories' EPS (Basic) is $3.43, which was down 6.28% from $3.66 recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' EPS (Basic) peaked at $3.66 during Q2 2025, and registered a low of $1.57 during Q2 2022.
  • Its 3-year average for EPS (Basic) is $2.82, with a median of $2.70 in 2023.
  • Its EPS (Basic) has fluctuated over the past 5 years, first spiked by 82.44% in 2021, then crashed by 33.76% in 2022.
  • Quarterly analysis of 5 years shows Idexx Laboratories' EPS (Basic) stood at $1.92 in 2021, then grew by 8.33% to $2.08 in 2022, then climbed by 12.50% to $2.34 in 2023, then rose by 13.25% to $2.65 in 2024, then climbed by 21.20% to $3.43 in 2025.
  • Its EPS (Basic) stands at $3.43 for Q3 2025, versus $3.66 for Q2 2025 and $2.98 for Q1 2025.